“We will vote against the re-election of Mr. Winkeljohann,” fund manager Janne Werning told Wirtschaftswoche. He pointed out the large number of mandates held by the chief controller: “The accumulation of offices is blatant.”
Werning said that the chairmanship of the supervisory board at Bayer is not a part-time job. “Bayer has big tasks ahead of him, it’s about reviewing the group structure and restoring the damaged confidence in the capital market.” At the Annual Stockholders’ Meeting on April 28, stockholders will vote on the composition of the Bayer Supervisory Board. With a stake of one percent, Union Investment is one of Bayer’s largest shareholders.
Winkeljohann is also Deputy Chairman of the Supervisory Board of Deutsche Bank. He also sits on the supervisory bodies of several medium-sized manufacturers. Since these are not listed on the stock exchange, many other investors see no problem in the mandates.
The invitation to Bayer’s Annual General Meeting states that the Supervisory Board has made sure that Winkeljohann “can invest the expected amount of time for the work on the company’s Supervisory Board, even taking into account” other mandates. Winkeljohann attended all meetings of the Supervisory Board and its committees in the 2022 financial year. He recently won the American Bill Anderson as the new CEO for Bayer.
FRANKFURT (Dow Jones)
Leverage must be between 2 and 20
No data
More news about Bayer
Image sources: Arseniy Krasnevsky / Shutterstock, Lukassek / Shutterstock.com